SEO URLwww.firestrike.ai/deals/terns-pharmaceuticals-merck-acquisition-2026-7
acquisitionAnnounced · May 6, 2026oncologySource · CredibleArticle · Factual
Merck acquires Terns Pharmaceuticals
David Najork · Founding Software Engineer
Announced · Updated · 1 min read
Deal value
$6.7B
Target
Terns Pharmaceuticals
NASDAQ: TERN · Foster City, California
Acquirer
Merck
Full Acquisition
Status
Pending
Merck agreed to acquire Terns Pharmaceuticals. Reported deal value: $6.7B. Status: Pending. Sector: oncology. Target headquarters context: Foster City, California, United States.
This page summarizes publicly available information about the transaction as of 2026-05-06. Figures and status may change as filings and press coverage update.
Merck Completes Acquisition of Terns Pharmaceuticals Inc.
Deal timeline
Announced
May 6, 2026 · biospace.com
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context
This transaction is classified in oncology with a reported deal value of $6.7B. Figures and status may change as sources update.
Sources: biospace.com · Primary article · FireStrike proprietary index